FDA approved the Varipulse pulsed field ablation (PFA) platform for drug refractory paroxysmal atrial fibrillation, Johnson & ...

Johnson & Johnson MedTech has received the US Food and Drug Administration (FDA) approval for its VARIPULSE Platform to treat ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to anti-arrhythmic drugs in patients with persistent AFib, a spokesperson said.

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

It has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have lost about 6.7% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

In a series of significant industry advancements, the U.S. FDA has given its nod to Johnson & Johnson's Varipulse device ...

Recent health news highlights include FDA approval for a Johnson & Johnson heart device, Canada's approval of Moderna's RSV ...